Learn how Merck is utilizing generative artificial intelligence (AI) and AWS technology to enhance its research and manufacturing processes – with an aim to deliver faster access to life-saving medicines.

Merck has built advanced analytic tools that provide end-to-end visibility across its value chain – which has reduced false rejection rates and accelerated investigation times from weeks to mere seconds.

Key points covered:

• Unlock data: End-to-end visibility across the value chain through unified data ecosystems using Amazon S3 and Amazon Redshift.

• Generative AI and advanced analytics: Reducing false rejects by over 80% and speeding investigation times from weeks to seconds.

Benefits of using AWS services: Enables Merck to transform drug development, optimize production, and deliver critical medicines to patients faster. Watch the video to see how Merck is accelerating biopharmaceutical innovation – and discover how to inspire your own cloud and AI transformation.